Related Experiment Video
Updated: Aug 22, 2025

In Vitro Culture of Epicardial Cells From Mouse Embryonic Heart
Published on: April 27, 2016
Complement factor D derived from epicardial adipose tissue participates in cardiomyocyte apoptosis after myocardial
Shuang Hao1, Jingchao Zhang1, Yu Pei1
1Department of Cardiac Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
Insights
Epicardial adipose tissue (EAT) secretes complement factor D (CFD) after myocardial infarction (MI), promoting cardiomyocyte apoptosis via PARP-1 activation. Inhibiting CFD alleviates this damage, offering a potential therapeutic target for heart failure post-MI.
Area of Science:
- Cardiology
- Molecular Biology
- Pathophysiology
Background:
- Acute myocardial infarction (MI) is a primary cause of congestive heart failure.
- Understanding the underlying pathophysiological processes is crucial for developing interventions.
Purpose of the Study:
- To analyze the pathophysiological mechanisms of acute MI.
- To identify key therapeutic targets for MI-induced heart failure.
Main Methods:
- Established a rat model of MI by ligating the left anterior descending branch.
- Collected heart, epicardial adipose tissue (EAT), and subcutaneous adipose tissue (SAT).
- Utilized H9c2 cells to investigate the role of complement factor D (CFD) in cardiomyocyte apoptosis.
Main Results:
- MI rats exhibited myocardial apoptosis and increased EAT.
- EAT-conditioned medium reduced H9c2 cell activity.
- Elevated CFD in EAT promoted cardiomyocyte apoptosis via PARP-1 activation, which was reversed by CFD inhibition (CFD-IN1).
Conclusions:
- Epicardial adipose tissue (EAT) mediates cardiomyocyte apoptosis following MI.
- CFD secretion by EAT and subsequent PARP-1 activation are key mechanisms.
- Inhibition of CFD presents a potential therapeutic strategy for MI.
Background:
Acute myocardial infarction (MI) is considered to be the main cause of congestive heart failure. The aim of this study was to provide an in-depth analysis of athophysiological processes and provide key targets for intervention in the occurrence of acute MI.
Methods:
A rat model of MI was established by ligation of left anterior descending branch. Heart tissue, epicardial adipose tissue (EAT) and subcutaneous adipose tissue (SAT) were collected. H9c2 cells were used to explore the mechanism of complement factor D (CFD) regulating cardiomyocyte apoptosis.
Results:
Myocardial apoptosis were observed in MI rat, and more EAT was found in the MI group in vivo. The conditioned medium prepared by EAT (EAT-CM) significantly reduced the activity of H9c2 cells. The content of CFD in EAT was significantly increased, and CFD promoted cardiomyocyte apoptosis in vitro and CFD-IN1 (a selective inhibitor of CFD) could revised this effect. CFD induced poly ADP-ribosepolymerase-1 (PARP-1) overactivation. Furthermore, the addition of pan-caspase inhibitor Z-VAD in the SAT-CM + CFD group couldn't affect H9c2 cell apoptosis. CFD induced cell apoptosis via PARP-1 activation and PARP-1 inhibitor 3-Aminobenzamide could revise this effect. The injection of CFD-IN1 in MI rat model confirmed that inhibition of CFD activity alleviated cardiomyocytes apoptosis.
Conclusion:
Our findings indicate that EAT mediating cardiomyocyte apoptosis after MI through secretion of CFD and activation of PARP-1 activity.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
The Extrinsic Apoptotic Pathway
Pathophysiology of Heart Failure
Coronary Artery Disease II: Pathophysiology

